Evidence map›Paper›PMID 39204239›Full record

ArticlePathogens (Basel, Switzerland)2024

mRNA Profiling and Transcriptomics Analysis of Chickens Received Newcastle Disease Virus Genotype II and Genotype VII Vaccines.

Putri Pandarangga, Phuong Thi Kim Doan, Rick Tearle, Wai Yee Low, Yan Ren, Hanh Thi Hong Nguyen, Niluh Indi Dharmayanti, Farhid Hemmatzadeh

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Putri PandaranggaDepartemen Klinik, Reproduksi, dan Patologi, Fakultas Kedokteran dan Kedokteran Hewan, Universitas Nusa Cendana, Kupang 85001, Indonesia.ORCID 0000-0003-2574-6231
Phuong Thi Kim DoanSchool of Animal and Veterinary Sciences, University of Adelaide, Adelaide 5371, Australia.ORCID 0000-0001-8692-5335
Rick TearleDavies Research Centre, School of Animal and Veterinary Sciences, University of Adelaide, Adelaide 5371, Australia.
Wai Yee LowDavies Research Centre, School of Animal and Veterinary Sciences, University of Adelaide, Adelaide 5371, Australia.ORCID 0000-0002-0749-765X
Yan RenDavies Research Centre, School of Animal and Veterinary Sciences, University of Adelaide, Adelaide 5371, Australia.ORCID 0000-0002-5465-980X
Hanh Thi Hong NguyenSchool of Animal and Veterinary Sciences, University of Adelaide, Adelaide 5371, Australia.
Niluh Indi DharmayantiNational Research and Innovation Agency, Jakarta 10340, Indonesia.
Farhid HemmatzadehSchool of Animal and Veterinary Sciences, University of Adelaide, Adelaide 5371, Australia.ORCID 0000-0002-4572-8869

Funding

Australian Centre for International Agricultural Research AH/2015/003
6 · The paper itself

Abstract

Newcastle Disease Virus (NDV) genotype VII (GVII) is becoming the predominant strain of NDV in the poultry industry. It causes high mortality even in vaccinated chickens with a common NDV genotype II vaccine (GII-vacc). To overcome this, the killed GVII vaccine has been used to prevent NDV outbreaks. However, the debate about vaccine differences remains ongoing. Hence, this study investigated the difference in chickens' responses to the two vaccines at the molecular level. The spleen transcriptomes from vaccinated chickens reveal that GVII-vacc affected the immune response by downregulating neuroinflammation. It also enhanced a synaptogenesis pathway that operates typically in the nervous system, suggesting a mechanism for the neurotrophic effect of this strain. We speculated that the down-regulated immune system regulation correlated with protecting the nervous system from excess leukocytes and cytokine activity. In contrast, GII-vacc inhibited apoptosis by downregulating PERK/ATF4/CHOP as part of the unfolded protein response pathway but did not affect the expression of the same synaptogenesis pathway. Thus, the application of GVII-vacc needs to be considered in countries where GVII is the leading cause of NDV outbreaks. The predicted molecular signatures may also be used in developing new vaccines that trigger specific genes in the immune system in combating NDV outbreaks.

Indexed as

ChickensGene Expression ProfilingNewcastle DiseaseNewcastle disease virusViral VaccinesAnimalsGenotypePoultry DiseasesRNA, MessengerSpleenTranscriptomeRNA, MessengerViral VaccinesNDV genotype IINDV genotype VIIsynaptogenesis pathwaytranscriptomicvaccine

Identifiers

PMID39204239
PMCPMC11357267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.